ReviewMedical devices (Auckland, N.Z.)2026
Female Supine Urination Tech: Patent Landscape & Indicators.
Review in Medical devices (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Female urination in the supine position is a frequent bedside need, yet common workarounds (bedpans, diapers, improvised receptacles) can be uncomfortable, increase caregiver workload, and contribute to potentially avoidable urinary catheterization. We mapped the patent landscape of non-invasive female urine-collection technologies intended for supine use and derived actionable innovation and access priorities. Methods: We searched Espacenet (EPO), WIPO PATENTSCOPE, the USPTO database, Google Patents, and INVENES for January 2000-September 2025. Records were screened for functional relevance to female supine voiding and de-duplicated at the DOCDB family level. For each patent family we extracted priority/publication timing, jurisdictions, assignees, IPC/CPC codes, and forward citations; coded solution archetypes; and coded adoption-relevant attributes (workflow feasibility, infrastructure dependence, and single-use vs reusable design intent). A structured multi-domain appraisal (0-2 per domain; total 0-12) was applied to representative families to support consistent comparison. Results: Twenty-six patent families met inclusion criteria. Innovation activity was sustained but low-intensity and uneven over time, with most filings clustered in 2010-2020; interpretation of late years was limited by publication lag. Most inventions followed single-use/disposable pathways (≈69%). The set covered 16 IPC subclasses, although >60% of families were concentrated in A61F 5/455. Passive external collectors showed the strongest maturity signals. Adhesive patch-type and intravaginal concepts were sporadic and heterogeneous. Suction/capillary approaches introduced stronger containment mechanisms but increased dependence on external infrastructure and proprietary consumables, limiting feasibility in home care and low-resource settings. Conclusion: The most consistent gap lies at the intersection of ergonomics, autonomy, and reusability-female-specific supine interfaces that contain leakage without adhesives or invasive elements, operate passively or with minimal infrastructure, and enable sterilizable/reusable pathways. Priorities for R&D include usability- and risk-informed evaluation, sustainability-by-design, and access-oriented IP strategies to support diffusion beyond high-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.